TM editors' note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence.
Company: Celltrion Incorporated
Bloomberg ticker: 068270 KS
Market cap: US$22,944m
Background: Celltrion Incorporated is one of Korea’s biggest exporters by value of biosimilar pharmaceutical products; a biosimilar is a cheaper version of a biopharmaceutical, a type of drug which is derived from biological rather than chemical sources. Like with a generic drug, the development costs are low.
World Class Benchmarking of Celltrion
(Click on image to enlarge)
- Profitable Growth rank of 4 was up compared to the prior period’s 6th rank
- This is above average performance compared to 180 large Health Care companies worldwide
- Profitability rank of 4 was better than its Growth rank of 6
- Profitability rank of 4 was the same compared to the prior period’s 4th rank
- This is above average performance compared to peers
- Growth rank of 6 was up compared to the prior period’s 9th rank
- This is below average performance compared to peers
Comments
Log in or sign up to join the conversation.